Thomas F. Gamage
Affiliations: | 2008-2014 | Pharmacology and Toxicology | Virginia Commonwealth University, Richmond, VA, United States |
| 2014-2016 | Center for Substance Abuse Research | Temple University, Philadelphia, PA, United States | |
| 2016- | Analytical Chemistry and Pharmaceutics | RTI International |
Area:
molecular and behavioral pharmacology, allosteric modulation, cannabinoids, opioids, drug abuse, dependenceGoogle:
"Thomas Gamage"Mean distance: 15.69 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Jenny L. Wiley | grad student | 2008-2009 | VCU | |
| Aron H. Lichtman | grad student | 2009-2014 | VCU | |
| (Differential effects of endocannabinoid catabolic inhibitors on opioid withdrawal in mice.) | ||||
| Brian F. Thomas | post-doc | 2016- | RTI International | |
| Mary E. Abood | post-doc | 2014-2016 | Temple University (Cell Biology Tree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wiley JL, Marusich JA, Blough BE, et al. (2024) Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 132: 110984 |
| Marusich JA, Gamage TF, Zhang Y, et al. (2022) In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists. Pharmacology, Biochemistry, and Behavior. 220: 173467 |
| Finlay DB, Nguyen T, Gamage TF, et al. (2022) Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018. Pharmacology Research & Perspectives. 10: e00901 |
| Nguyen T, Gamage TF, Decker AM, et al. (2021) Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids. Bioorganic & Medicinal Chemistry. 41: 116215 |
| Wiley JL, Barrus DG, Farquhar CE, et al. (2020) Sex, species and age: Effects of rodent demographics on the pharmacology of ∆-tetrahydrocanabinol. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110064 |
| Gamage TF, Barrus DG, Kevin RC, et al. (2020) In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018. Pharmacology, Biochemistry, and Behavior. 172918 |
| Nguyen T, Gamage T, Decker AM, et al. (2019) Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators. Journal of Medicinal Chemistry |
| Kevin RC, Kovach AL, Lefever TW, et al. (2019) Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic Toxicology. 37: 17-26 |
| Gamage TF, Farquhar CE, McKinnie RJ, et al. (2018) Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors. The Journal of Pharmacology and Experimental Therapeutics |
| Farquhar CE, Breivogel CS, Gamage TF, et al. (2018) Sex, THC, and hormones: Effects on density and sensitivity of CB cannabinoid receptors in rats. Drug and Alcohol Dependence. 194: 20-27 |